<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03006289</url>
  </required_header>
  <id_info>
    <org_study_id>qfsnfm-003</org_study_id>
    <nct_id>NCT03006289</nct_id>
  </id_info>
  <brief_title>Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer</brief_title>
  <official_title>Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lin Liao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qianfoshan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the association between metabolic syndrome (MS),&#xD;
      body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen&#xD;
      for the risk factors that affect the incidence of thyroid cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>lipids</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>glucose</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>blood pressure</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Uric Acid</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>sialic acid</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>thyroid function</measure>
    <time_frame>before the thyroid surgery</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Thyroid Cancer</condition>
  <arm_group>
    <arm_group_label>The thyroid cancer group</arm_group_label>
    <description>The postoperative pathology of thyroid is malignant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The thyroid nodule group</arm_group_label>
    <description>The postoperative pathology of thyroid is benign</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergone thyroid surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patients undergone thyroid surgery&#xD;
&#xD;
          2. signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1.patients with no surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lin Liao, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Qianfoshan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lin Liao, MD</last_name>
    <phone>8615168888260</phone>
    <email>liaolin@medmail.com.cn</email>
  </overall_contact>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>December 26, 2016</study_first_submitted>
  <study_first_submitted_qc>December 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2016</study_first_posted>
  <last_update_submitted>December 26, 2016</last_update_submitted>
  <last_update_submitted_qc>December 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Qianfoshan Hospital</investigator_affiliation>
    <investigator_full_name>Lin Liao</investigator_full_name>
    <investigator_title>chief of endocrinology department at Qianfoshan Hospital</investigator_title>
  </responsible_party>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>fasting plasma glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03006289
org study id: qfsnfm-003
nct id: NCT03006289
lead sponsor: 
has dmc: Yes
The purpose of this study is to investigate the association between metabolic syndrome (MS),
      body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen
      for the risk factors that affect the incidence of thyroid cancer.
measure: lipids
time frame: before the thyroid surgery
measure: glucose
time frame: before the thyroid surgery
measure: blood pressure
time frame: before the thyroid surgery
measure: Uric Acid
time frame: before the thyroid surgery
measure: sialic acid
time frame: before the thyroid surgery
measure: thyroid function
time frame: before the thyroid surgery
arm group label: The thyroid cancer group
description: The postoperative pathology of thyroid is malignant
arm group label: The thyroid nodule group
description: The postoperative pathology of thyroid is benign
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: 8 Years
maximum age: 80 Years
healthy volunteers: Accepts Healthy Volunteers
last name: Lin Liao, MD
role: Study Chair
affiliation: Qianfoshan Hospital
last name: Lin Liao, MD
phone: 8615168888260
email: liaolin@medmail.com.cn
responsible party type: Sponsor-Investigator
investigator affiliation: Qianfoshan Hospital
investigator full name: Lin Liao
investigator title: chief of endocrinology department at Qianfoshan Hospital
mesh term: Thyroid Neoplasms
mesh term: Metabolic Syndrome
mesh term: Thyroid Diseases
sharing ipd: Yes